![]() |
|
|
NICR recognizes trends in managed healthcare and consequent limited revenues. An ideal option exists for physicians to engage in pharmaceutical, device and biotech clinical research trials appropriate for your practice through which to achieve additional revenue, provide patients with emerging, efficacious therapies and maintain an important channel to medical infomatics within your clinical category. NICR provides physicians opportunity to start their first study, expand current trial operations and/or further develop their clinical research business through acquisition, partnering & merger.consequent limited revenues. An ideal option exists for physicians to engage in pharmaceutical, device and biotech clinical research trials appropriate for your practice through which to achieve additional revenue, provide patients with emerging, efficacious therapies and maintain an important channel to medical infomatics within your clinical category. NICR provides physicians opportunity to start their first study, expand current trial operations and/or further develop their clinical research business through acquisition, partnering & merger.consequent limited revenues. An ideal option exists for physicians to engage in pharmaceutical, device and biotech clinical research trials appropriate for your practice through which to achieve additional revenue, provide patients with emerging, efficacious therapies and maintain an important channel to medical infomatics within your clinical category. NICR provides physicians opportunity to start their first study, expand current trial operations and/or further develop their clinical research business through acquisition, partnering & merger. |
|||||||||||||||||||||||||||||||
© NICR Copyright 1999-2002. |